May 30, 2023, 4:15 p.m. | PR Newswire

AI – AI-TechPark ai-techpark.com

Today, XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to de novo design and...


The post XtalPi Announces Collaboration with Lilly first appeared on AI-TechPark.

ai capabilities artificial artificial intelligence automation collaboration design discovery drug discovery intelligence payments pharmaceutical platform robotics technology xtalpi

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne